Results 181 to 190 of about 17,459 (201)

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly  

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly  

[Prevention strategy for invasive meningococcal disease].

La Revue du praticien
PREVENTION STRATEGY FOR INVASIVE MENINGOCOCCAL DISEASE. The prevention strategy for invasive meningococcal disease (IMD) includes vaccination and antibiotic prophylaxis in the vicinity of a case. IMD is unpredictable, difficult to recognize at an early stage, and very severe, with a mortality rate about 10 %, and 20 to 25 % of survivors suffering from ...
openaire   +1 more source

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Robert A Smith, Stacey A Fedewa
exaly  

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Brian O'Sullivan   +2 more
exaly  

Invasive Meningococcal Disease Outbreak Management

Pediatric Infectious Disease Journal
Adriana Milazzo, Helen S. Marshall
openaire   +1 more source

Adolescent and young adult oncology—past, present, and future

Ca-A Cancer Journal for Clinicians, 2019
Allison G Close, Kimberly D Miller, Louis B Rapkin   +2 more
exaly  

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

[After-effects of invasive meningococcal diseases].

La Revue du praticien
AFTER-EFFECTS OF INVASIVE MENINGOCOCCAL DISEASES. Invasive meningococcal infections (IMI) still have a mortality rate of 11% in France. Recent nationwide studies have been able to quantify the long-term sequelae among survivors and highlight their diversity.
openaire   +1 more source

State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now

Ca-A Cancer Journal for Clinicians, 2016
Susan M Swetter
exaly